Adherence to aromatase inhibitors (AIs) in Hispanic patients with early stage breast cancer

被引：2
|
作者：
Philipovskiy, Alexander
Campbell, Aleli
Heydarian, Rosalinda
Lin, Krysta
Nahleh, Zeina A.
机构：
[1] Texas Tech Univ, Hlth Sci Ctr, El Paso, TX USA
[2] Univ Texas El Paso, El Paso, TX 79968 USA
[3] Cleveland Clin Florida, Weston, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 07期
关键词：
D O I：
10.1200/JCO.2018.36.7_suppl.70
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
70
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Aromatase, aromatase inhibitors, and breast cancer
    Chumsri, Saranya
    Howes, Timothy
    Bao, Ting
    Sabnis, Gauri
    Brodie, Angela
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2011, 125 (1-2): : 13 - 22
  • [42] Changes in body composition in early breast cancer patients treated with aromatase inhibitors
    Pedersini, R.
    Schivardi, G.
    Laini, L.
    Zamparini, M.
    Bonalumi, A.
    di Mauro, P.
    Bosio, S.
    Amoroso, V.
    Villa, N.
    Alberti, A.
    Di Meo, N.
    Gonano, C.
    Zanini, B.
    Lagana, M.
    Ippolito, G.
    Rinaudo, L.
    Farina, D.
    Castellano, M.
    Cappelli, C.
    Simoncini, E. L.
    Cosentini, D.
    Berruti, A.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2024,
  • [43] BREAST CANCER, ILLNESS PERCEPTIONS AND NON-ADHERENCE TO AROMATASE INHIBITORS
    Corter, Arden
    Findlay, Michael P.
    Broom, Reuben
    Porter, David
    Petrie, Keith J.
    [J]. INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2010, 17 : 5 - 5
  • [44] Bone Health Issues in Women with Early-stage Breast Cancer Receiving Aromatase Inhibitors
    Brufsky, Adam M.
    [J]. CURRENT ONCOLOGY REPORTS, 2008, 10 (01) : 18 - 26
  • [45] Bone density screening in postmenopausal women with early-stage breast cancer on aromatase inhibitors
    Stratton, Jamie
    Hu, Xin
    Soulos, Pamela R.
    Davidoff, Amy J.
    Pusztai, Lajos
    Gross, Cary Philip
    Mougalian, Sarah Schellhorn
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [46] Adjuvant aromatase inhibitors in early breast cancer - toxicity and adherence. Important observations in clinical practice
    Dent, S. F.
    Hopkins, S.
    Di Valentin, T.
    Verreault, J.
    Vandermeer, L.
    Verma, S.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S111 - S111
  • [47] Prevalence of joint symptoms in postmenopausal women on aromatase inhibitors for early stage breast cancer.
    Crew, K. D.
    Apollo, A.
    Greenlee, H.
    Raptis, G.
    Braffman, L.
    Fuentes, D.
    Hershman, D. L.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S235 - S235
  • [48] Bone health issues in women with early-stage breast cancer receiving aromatase inhibitors
    Adam M. Brufsky
    [J]. Current Oncology Reports, 2008, 10 : 18 - 26
  • [49] Markers of Bone Metabolism in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer
    Barginear, Myra
    Clotfelter, Anne
    Van Poznak, Catherine
    [J]. CLINICAL BREAST CANCER, 2009, 9 (02) : 72 - 76
  • [50] Managing bone loss in women with early-stage breast cancer receiving aromatase inhibitors
    Brufsky, Adam M.
    [J]. CLINICAL BREAST CANCER, 2007, 8 : S22 - S34
12345